Filgotinib for treating moderate to severe rheumatoid arthritis – final appraisal document

In DRAFT guidance, NICE recommends filgotinib for the treatment of rheumatoid arthritis in adults with moderate to severe active rheumatoid arthritis, according to the stated criteria.

Source:

National Institute for Health and Care Excellence